Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for BioLineRx (BLRX) over the last 2 years, with Q3 2025 value amounting to -$568000.0.

  • BioLineRx's Change in Accured Expenses rose 307.17% to -$568000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year change of. This contributed to the annual value of -$3.9 million for FY2013, which is N/A changed from last year.
  • As of Q3 2025, BioLineRx's Change in Accured Expenses stood at -$568000.0, which was up 307.17% from $25000.0 recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Change in Accured Expenses registered a high of $25000.0 during Q2 2025, and its lowest value of -$3.5 million during Q1 2024.